Esketamine first received FDA approval in 2019, but with an important restriction: it could only be used in combination with an oral antidepressant. That requirement, built into the original label and ...
Morning Overview on MSN
Ultrasound-triggered nanoparticles create light in tissue for therapy
Delivering light to a tumor buried centimeters inside the body has always required threading a fiber-optic cable through ...
Clinical trial quality starts with culture. Learn how one company’s ethical lapses led to bankruptcy—and how the ASPIRE ...
Briya, the health AI technology company redefining healthcare research, today announced its global data network has expanded to cover over 120 million patient records. By unifying this massive ...
A major step forward in neonatal care will be underway Tuesday as Memorial Health becomes one of only three hospitals in the ...
FDA grants Fast Track Designation for Daretabart (hu1418K322A), recognising the significant unmet medical need in high-risk ...
Revolution Medicines shared Phase III clinical trial results for a pill called daraxonrasib in patients with previously ...
Step therapy, commonly referred to as ”fail first”, was designed to control costs by requiring patients to try lower-cost therapies before accessing the treatment originally prescribed. In theory, it ...
The Food and Drug Administration will announce on Monday that it has sent over 2,200 letters pressing drug manufacturers, ...
PRO-XTEN dual masking aims to keep the engager inactive in circulation, activate within tumor protease-rich microenvironments ...
Kailera is taking another step into the competitive obesity market by aiming to raise up to $528.5 million via a Nasdaq IPO, ...
Post-thrombotic syndrome is common after deep-vein thrombosis and can cause severe symptoms involving the limbs that impair patients’ activity and quality of life. Endovascular therapy can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results